A little while after getting the vaccine she required hospitalization for thrombocytopenia; Her body was bleeding; She had vaginal bleeding nonstop and that's why she was hospitalized; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jan-2022 and was forwarded to Moderna on 14-Jan-2022.    This spontaneous case was reported by a consumer and describes the occurrence of THROMBOCYTOPENIA (A little while after getting the vaccine she required hospitalization for thrombocytopenia), HAEMORRHAGE (Her body was bleeding) and VAGINAL HAEMORRHAGE (She had vaginal bleeding nonstop and that's why she was hospitalized) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOCYTOPENIA (A little while after getting the vaccine she required hospitalization for thrombocytopenia) (seriousness criteria hospitalization and medically significant), HAEMORRHAGE (Her body was bleeding) (seriousness criteria hospitalization and medically significant) and VAGINAL HAEMORRHAGE (She had vaginal bleeding nonstop and that's why she was hospitalized) (seriousness criterion hospitalization). At the time of the report, THROMBOCYTOPENIA (A little while after getting the vaccine she required hospitalization for thrombocytopenia), HAEMORRHAGE (Her body was bleeding) and VAGINAL HAEMORRHAGE (She had vaginal bleeding nonstop and that's why she was hospitalized) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: 8000 (Low) Low platelet level of 8000 and it was supposed to be 150000.         Concomitant medications were not reported.  Treatment information was not provided by the reporter.  Patient received 2 doses of the Moderna COVID-19 Vaccine.  A little while after getting the vaccine, patient required hospitalization for thrombocytopenia. Patient's body was bleeding and had vaginal bleeding non-stop and that was why patient was hospitalized.  Company Comment : This RA case concerns a 27 year old female , with no medical history reported, who experienced Serious  ( Medically significant , Hospitalizaiton ) , unexpected, AESI event of thrombocytopenia which occurred on an unknown date post vaccination  with an unknown dose number  of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) , This was accompanied by other Serious , unexpected events of hemorrhage and vaginal hemorrhage which also occurred on an unknown date post vaccination with an unknown dose number of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . This patient was hospitalized because of the bleeding and was found out to have low platelet count, there were no other details reported re the hospitalization. The re-challenge for this case is not applicable since the events outcome is unknown and also the dose details are also unknown, The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This RA case concerns a 27 year old female , with no medical history reported, who experienced Serious  ( Medically significant , Hospitalizaiton ) , unexpected, AESI event of thrombocytopenia which occurred on an unknown date post vaccination  with an unknown dose number  of mRNA-1273 vaccine ( Moderna Covid 19 vaccine ) , This was accompanied by other Serious , unexpected events of hemorrhage and vaginal hemorrhage which also occurred on an unknown date post vaccination with an unknown dose number of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . This patient was hospitalized because of the bleeding and was found out to have low platelet count, there were no other details reported re the hospitalization. The re-challenge for this case is not applicable since the events outcome is unknown and also the dose details are also unknown, The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.